EGFR and prostate carcinoma: EGFR function, as judged by Y845 and Y1068 phosphorylations, has also been implicated in the anti-apoptosis of PC-3 prostate cancer cells, for which the combined application of β-phenylethyl isothiocyanate and curcumin leads to apoptotic cell death [147].